miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells

Area of Science:

• Molecular Biology
• Renal Cell Biology
• Immunology

Background:

• Renal mesangial cells (RMCs) are crucial in renal inflammation via inflammatory cytokine production.
• MicroRNAs (miRNAs) regulate inflammatory cytokine expression, and their dysregulation is linked to kidney inflammation.
• The specific roles of renal miRNAs in inflammatory signaling pathways remain largely unexplored.

Purpose of the Study:

• To investigate the function of miR-744 in the type I interferon (IFN) signaling pathway within primary human RMCs.
• To elucidate the molecular targets and regulatory mechanisms of miR-744 in RMCs.

Main Methods:

• Overexpression of miR-744 in primary human RMCs.
• Measurement of inflammatory cytokine expression (CCL2, CCL5, CXCL10, IL6) and signaling pathway activation (TYK2, STAT1, STAT3, ERK, p38).
• Identification of miR-744 targets using molecular assays, focusing on PTP1B.

Main Results:

• miR-744 overexpression significantly enhanced type I IFN-induced expression of CCL2, CCL5, CXCL10, and IL6 in RMCs.
• miR-744 boosted the activation of key signaling molecules including TYK2, STAT1, STAT3, ERK, and p38.
• Protein tyrosine phosphatase 1B (PTP1B) was identified as a direct target of miR-744, mediating the enhanced type I IFN response.

Conclusions:

• miR-744 acts as a positive regulator of the type I IFN signaling pathway in RMCs by targeting PTP1B.
• miR-744 exhibits a feed-forward regulatory role, amplifying the type I IFN response in kidney cells.
• These findings provide novel insights into miRNA-mediated regulation of inflammatory signaling in the kidney.